Clareon PanOptix Pro PXYAT0 (REF PXYAT0.210)Recalls & reported problems
Alcon Laboratories, Inc. · CL PANOPTIX PRO ATME BLF · Class 3 · Implant
All models of Clareon PanOptix Pro (222)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380658493301), received between Jan 30, 2026 and May 22, 2026 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Device Difficult to Setup or Prepare” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Device Difficult to Setup or Prepare1
Patient problems
- Blurred Vision2
- Visual Disturbances2
- Insufficient Information1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 22, 2026Device Difficult to Setup or Prepare
A HEALTHCARE PROFESSIONAL REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, HAPTIC GOT CAUGHT AND LENS WAS NOT IMPLANTED. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT IS NOT AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: Insufficient Information
MAUDE report 25257084 ↗InjuryJan 30, 2026Adverse Event Without Identified Device or Use Problem
A CONSUMER CALLED TO REPORT SHE WAS HAVING EXTREME HALOS AT NIGHT, CAUSING DIFFICULTY IN DRIVING AND HAVING SHADOWS BEHIND LETTERS WHEN TRYING TO READ. DISTANCE VISION DURING THE DAY WAS GOOD. HAD SPOKEN TO HER SURGEON, HE HAD TREATED FOR DRY EYE AND DETERMINED SHE DID NOT HAVE DRY EYE. HAD BEEN TREATED WITH A DRUG WHICH BELONGS TO THE MIOTICS TO REDUCE PUPIL SIZE WHICH HAD NOT HELPED. ADDITIONAL INFORMATION HAS BEEN REQUESTED. THERE ARE TWO MEDICAL REPORTS ASSOCIATED WITH THIS PATIENT. THIS FILE IS FOR LEFT EYE.
Patient problems: Blurred Vision; Visual Disturbances
MAUDE report 24220845 ↗InjuryJan 30, 2026Adverse Event Without Identified Device or Use Problem
A CONSUMER CALLED TO REPORT SHE WAS HAVING EXTREME HALOS AT NIGHT, CAUSING DIFFICULTY IN DRIVING AND HAVING SHADOWS BEHIND LETTERS WHEN TRYING TO READ. DISTANCE VISION DURING THE DAY WAS GOOD. HAD SPOKEN TO HER SURGEON, HE HAD TREATED FOR DRY EYE AND DETERMINED SHE DID NOT HAVE DRY EYE. HAD BEEN TREATED WITH A DRUG WHICH BELONGS TO THE MIOTICS TO REDUCE PUPIL SIZE WHICH HAD NOT HELPED. ADDITIONAL INFORMATION HAS BEEN REQUESTED. THERE ARE TWO MEDICAL REPORTS ASSOCIATED WITH THIS PATIENT. THIS FILE IS FOR RIGHT EYE.
Patient problems: Blurred Vision; Visual Disturbances
MAUDE report 24220687 ↗
Other Lens, Multifocal Intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page